Premium functions are now FREE OF CHARGE due to the modification of the investment data Data developments may cause some parts work incorrectly Incorrect sections - Financial statements, Earnings upcoming dates and calendars Please take our apologise. It will be fixed soon

PRGO - Perrigo Company plc


Close
29.1
0.100   0.344%

Share volume: 837,747
Last Updated: Fri 30 Aug 2024 10:00:02 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%

$29.00
0.10
0.35%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
23%
Profitability 7%
Dept financing 34%
Liquidity 73%
Performance 24%
Company vs Stock growth
vs
Performance
5 Days
0.44%
1 Month
3.85%
3 Months
7.64%
6 Months
13.48%
1 Year
-15.16%
2 Year
-17.14%
Key data
Stock price
$29.10
P/E Ratio 
-31.89
DAY RANGE
$28.80 - $29.18
EPS 
-$0.91
52 WEEK RANGE
$24.58 - $34.54
52 WEEK CHANGE
-$0.16
MARKET CAP 
3.970 B
YIELD 
3.73%
SHARES OUTSTANDING 
136.415 M
DIVIDEND
$0.276
EX-DIVIDEND DATE
08/30/2024
NEXT EARNINGS DATE
11/05/2024
BETA 
0.47
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$926,146
AVERAGE 30 VOLUME 
$1,300,706
Company detail
CEO: Murray Kessler
Region: US
Website: https://www.perrigo.com/
Employees: 5,210
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

perrigo company plc, a top five global over-the-counter (otc) consumer goods and pharmaceutical company, offers consumers and customers high quality products at affordable prices. from its beginnings in 1887 as a packager of generic home remedies, perrigo, headquartered in ireland, has grown to become the world's largest manufacturer of otc products and supplier of infant formulas for the store brand market. the company is also a leading provider of branded otc products, generic extended topical prescription products and receives royalties from multiple sclerosis drug tysabri®. perrigo provides “quality affordable healthcare products®” across a wide variety of product categories and geographies primarily in north america, europe, and australia, as well as other key markets including israel and china. visit perrigo online at (http://www.perrigo.com).

Recent news